Drug recall · December 2, 2020
Felodipine Extended Release Tablets recall
Why: Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-01
- Lots / codes
Lot #: 18029979, Exp 1/2021
- Quantity
- 7176 bottles
- Company
- Heritage Pharmaceuticals Inc, East Brunswick, NJ
- Distribution
- USA Nationwide
- Initiated
- October 23, 2020 · Voluntary: Firm initiated
- Classified
- November 25, 2020
- Reported
- December 2, 2020
- Ended
- January 28, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Felodipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.